Patent · US Active

Method of inhibiting myopia and application of an adenylyl cyclase inhibitor as a drug for inhibiting myopia

US9084791B2 · kind B2 · utility

0Cited by
1References
1Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 21, 2011
Grant dateJul 21, 2015
Priority date
Expiry dateAug 2, 2033

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Methods for inhibiting myopia are disclosed. A method for inhibiting myopia includes reducing a level of an intraocular cAMP in a subject. The level of the intraocular cAMP is reduced by injecting an adenylyl cyclase inhibitor to achieve the inhibition of myopia in the subject. In one method, the adenylyl cyclase inhibitor is SQ22536.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.